Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v1-EN
Language English English
Date Updated 2023-12-02 2023-04-12
Drug Identification Number 02230988 02230988
Brand name CEREBYX CEREBYX
Common or Proper name Cerebyx 5x2ml Cerebyx 5x2ml
Company Name SEARCHLIGHT PHARMA INC SEARCHLIGHT PHARMA INC
Ingredients FOSPHENYTOIN SODIUM FOSPHENYTOIN SODIUM
Strength(s) 75MG 75MG
Dosage form(s) SOLUTION LIQUID SOLUTION LIQUID
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 5x2ml 5x2ml
ATC code N03AB N03AB
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-04-21 2023-04-21
Actual start date
Estimated end date 2023-12-01 2023-09-30
Actual end date 2023-12-01
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments